Cargando…

Robust antibody and CD8(+) T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection

Despite several decades of extensive research, the development of a highly efficacious malaria vaccine has yet to be accomplished. While the RTS,S malaria vaccine candidate shows the potential to prevent a substantial number of clinical malaria cases, significant improvements in protective efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Espinosa, Diego A., Christensen, Dennis, Muñoz, Christian, Singh, Sanjay, Locke, Emily, Andersen, Peter, Zavala, Fidel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603302/ https://www.ncbi.nlm.nih.gov/pubmed/28936360 http://dx.doi.org/10.1038/s41541-017-0011-y

Ejemplares similares

Applying Microfluidics for the Production of the Cationic Liposome-Based Vaccine Adjuvant CAF09b
por: Schmidt, Signe Tandrup, et al.
Publicado: (2020)

Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements
por: Agger, Else Marie, et al.
Publicado: (2008)

A Novel Prophylaxis Strategy Using Liposomal Vaccine Adjuvant CAF09b Protects against Influenza Virus Disease
por: Zimmermann, Julie, et al.
Publicado: (2022)

Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages
por: Huang, Wei-Chiao, et al.
Publicado: (2022)

Synthesis of protein conjugates adsorbed on cationic liposomes surface
por: Chatzikleanthous, Despo, et al.
Publicado: (2020)

Adsorption of protein antigen to the cationic liposome adjuvant CAF®01 is required for induction of Th1 and Th17 responses but not for antibody induction
por: Wørzner, Katharina, et al.
Publicado: (2021)

The P. falciparum CSP repeat region contains three distinct epitopes required for protection by antibodies in vivo
por: Flores-Garcia, Yevel, et al.
Publicado: (2021)

A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum
por: Beutler, Nathan, et al.
Publicado: (2022)

Targeting the Mincle and TLR3 receptor using the dual agonist cationic adjuvant formulation 9 (CAF09) induces humoral and polyfunctional memory T cell responses in calves
por: Thakur, Aneesh, et al.
Publicado: (2018)

Synthesis of aminyl biradicals by base-induced Csp(3)–Csp(3) coupling of cationic azo dyes
por: Liu, Yizhu, et al.
Publicado: (2019)

mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum
por: Hayashi, Clifford T. H., et al.
Publicado: (2022)

The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile
por: Schmidt, Signe Tandrup, et al.
Publicado: (2016)

P. falciparum and P. vivax Epitope-Focused VLPs Elicit Sterile Immunity to Blood Stage Infections
por: Whitacre, David C., et al.
Publicado: (2015)

Author Correction: mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum
por: Hayashi, Clifford T. H., et al.
Publicado: (2023)

DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity
por: Chuang, Ilin, et al.
Publicado: (2013)

First in man study: Bcl-Xl_42-CAF(®)09b vaccines in patients with locally advanced prostate cancer
por: Mørk, Sofie Kirial, et al.
Publicado: (2023)

ReverCSP: Time-Travelling in CSP Computations
por: Galindo, Carlos, et al.
Publicado: (2020)

Therapeutic Vaccination with Cationic Liposomes Formulated with Dioctadecyldimethylammonium and Trehalose Dibehenate (CAF01) and Peptide P10 Is Protective in Mice Infected with Paracoccidioides brasiliensis
por: de Araújo, Marcelo Valdemir, et al.
Publicado: (2020)

Adenovirus-5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part B: Safety, Immunogenicity and Protective Efficacy of the CSP Component
por: Tamminga, Cindy, et al.
Publicado: (2011)

Molecular and functional properties of human Plasmodium falciparum CSP C‐terminus antibodies
por: Oludada, Opeyemi Ernest, et al.
Publicado: (2023)

Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma
por: Mørk, Sofie Kirial, et al.
Publicado: (2022)

Preparation, characterization, and efficient transfection of cationic liposomes and nanomagnetic cationic liposomes
por: Samadikhah, Hamid Reza, et al.
Publicado: (2011)

Affinity-matured homotypic interactions induce spectrum of PfCSP structures that influence protection from malaria infection
por: Martin, Gregory M., et al.
Publicado: (2023)

Elution profile of cationic and anionic adsorbate from exhausted adsorbent using solvent desorption
por: Patel, Himanshu
Publicado: (2022)

Photoexcited Enzymes for Asymmetric Csp (3)−Csp (3) Cross‐Electrophile Couplings
por: Schmidt, Sandy
Publicado: (2022)

A DNA Vaccine Encoding Plasmodium falciparum PfRH5 in Cationic Liposomes for Dermal Tattooing Immunization
por: Fotoran, Wesley Luzetti, et al.
Publicado: (2020)

Optimization of an in vivo model to study immunity to Plasmodium falciparum pre-erythrocytic stages
por: Flores-Garcia, Yevel, et al.
Publicado: (2019)

Inducing Dose Sparing with Inactivated Polio Virus Formulated in Adjuvant CAF01
por: Dietrich, Jes, et al.
Publicado: (2014)

Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model
por: Ludwig, Julia, et al.
Publicado: (2023)

A Novel Liposome-Based Adjuvant CAF01 for Induction of CD8(+) Cytotoxic T-Lymphocytes (CTL) to HIV-1 Minimal CTL Peptides in HLA-A*0201 Transgenic Mice
por: Gram, Gregers Jacob, et al.
Publicado: (2009)

CSPα in neurodegenerative diseases
por: Huang, Liqin, et al.
Publicado: (2022)

A high-affinity antibody against the CSP N-terminal domain lacks Plasmodium falciparum inhibitory activity
por: Thai, Elaine, et al.
Publicado: (2020)

In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP)
por: Livingstone, Merricka C., et al.
Publicado: (2021)

Seasonal Influenza Split Vaccines Confer Partial Cross-Protection against Heterologous Influenza Virus in Ferrets When Combined with the CAF01 Adjuvant
por: Christensen, Dennis, et al.
Publicado: (2018)

Construction of congested Csp(3)–Csp(3) bonds by a formal Ni-catalyzed alkylboration
por: Simlandy, Amit Kumar, et al.
Publicado: (2021)

A Magnetic Adsorbent for the Removal of Cationic Dyes from Wastewater
por: Ji, Yumei, et al.
Publicado: (2018)

Irinotecan/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapy
por: Li, Zhaohuan, et al.
Publicado: (2021)

Syringe Free Vaccination with CAF01 Adjuvated Ag85B-ESAT-6 in Bioneedles Provides Strong and Prolonged Protection Against Tuberculosis
por: Christensen, Dennis, et al.
Publicado: (2010)

Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)
por: Sedegah, Martha, et al.
Publicado: (2013)

Preparation and Characterization of New Liposomes. Bactericidal Activity of Cefepime Encapsulated into Cationic Liposomes
por: Moyá, Maria Luisa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tj8nls1vgn9a9uuq2e44fms6n5